Compounds > 3',5'-dichloromethotrexate
Page last updated: 2024-08-21

3',5'-dichloromethotrexate and Hepatocellular Carcinoma

3',5'-dichloromethotrexate has been researched along with Hepatocellular Carcinoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ADAMSON, RH; LOO, TL; MORRIS, HP1
Bahendeka, S; Katongole-Mbidde, E; Kyalwazi, SK; Mugerwa, J; Olweny, CL; Otim, D1
Donehower, RC; Eddy, JL; Ihde, DC; Myers, CE; Tester, WJ1
Friedman, MA1
Eddy, JL; Ihde, DC; Makuch, RW; Matthews, MJ; McIntire, KR; Seeff, LB1

Reviews

1 review(s) available for 3',5'-dichloromethotrexate and Hepatocellular Carcinoma

ArticleYear
Hepatic intraarterial chemotherapy--current status and future prospects--"If you have a short sword, take a step forward".
    Gan to kagaku ryoho. Cancer & chemotherapy, 1983, Volume: 10, Issue:5

    Topics: Carcinoma, Hepatocellular; Catheterization; Colonic Neoplasms; Doxorubicin; Floxuridine; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Methotrexate; Rectal Neoplasms

1983

Other Studies

4 other study(ies) available for 3',5'-dichloromethotrexate and Hepatocellular Carcinoma

ArticleYear
Metabolism of C136-dichloromethotrexate by transplantable liver tumors.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1962, Volume: 111

    Topics: Carcinoma, Hepatocellular; Folic Acid Antagonists; Liver; Liver Neoplasms; Methotrexate

1962
Further experience in treating patients with hepatocellular carcinoma in Uganda.
    Cancer, 1980, Dec-15, Volume: 46, Issue:12

    Topics: Adolescent; Adult; Aged; alpha-Fetoproteins; Azacitidine; Carcinoma, Hepatocellular; Child; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Hepatic Artery; Humans; Injections, Intravenous; Ligation; Liver Neoplasms; Male; Methotrexate; Middle Aged; Pigmentation Disorders; Razoxane; Uganda

1980
Evaluation of weekly escalating doses of dichloromethotrexate in patients with hepatocellular carcinoma and other solid tumors.
    Cancer chemotherapy and pharmacology, 1982, Volume: 8, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Administration Schedule; Female; Humans; Liver Neoplasms; Male; Methotrexate; Middle Aged; Protein Binding; Serum Albumin

1982
Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival.
    The American journal of medicine, 1985, Volume: 78, Issue:3

    Topics: Adolescent; Adult; Aged; alpha-Fetoproteins; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Methotrexate; Middle Aged; Prognosis; Streptozocin; Time Factors

1985